A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy

Journal of Allergy and Clinical Immunology

Volumn 137, Issue 4, 2016, Pages 1103-1110.e11

  Wood, Robert A ^a   Kim, Jennifer S ^b   Lindblad, Robert ^c   Nadeau, Kari ^d   Henning, Alice K ^c   Dawson, Peter ^c   Plaut, Marshall ^e   Sampson, Hugh A ^f  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^c EMMES CORPORATION   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

desensitization; dose related adverse reactions; double blind; Milk allergy; omalizumab; oral immunotherapy; placebo controlled trial; sustained unresponsiveness

Indexed keywords

OMALIZUMAB; PLACEBO; ANTIALLERGIC AGENT;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG SAFETY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; MILK ALLERGY; MOUTH DISEASE; OPEN STUDY; ORAL IMMUNOTHERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; SKIN MANIFESTATION; TREATMENT OUTCOME; DESENSITIZATION; DRUG ADMINISTRATION; MILK HYPERSENSITIVITY; MULTIMODALITY CANCER THERAPY; ORAL DRUG ADMINISTRATION; PROCEDURES; STATISTICAL MODEL; YOUNG ADULT;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTI-ALLERGIC AGENTS; CHILD; COMBINED MODALITY THERAPY; DESENSITIZATION, IMMUNOLOGIC; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MILK HYPERSENSITIVITY; OMALIZUMAB; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84949033179     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2015.10.005     Document Type: Article

References (32)

1. J.A. Boyce, A. Assa'ad, A.W. Burks, S.M. Jones, H.A. Sampson, R.A. Wood, and et al. Guidelines for the diagnosis and management of food allergy in the united states: summary of the NIAID-sponsored expert panel report J Allergy Clin Immunol 126 2010 1105 1118
2. S.H. Sicherer Epidemiology of food allergy J Allergy Clin Immunol 127 2011 594 602
3. R.A. Wood, S.H. Sicherer, B.P. Vickery, S.M. Jones, A.H. Liu, D.M. Fleischer, et al. The natural history of milk allergy in an observational cohort J Allergy Clin Immunol 131 2013 805 812
4. J.M. Skripak, E.C. Matsui, K. Mudd, and R.A. Wood The natural history of IgE-mediated cow's milk allergy J Allergy Clin Immunol 120 2007 1172 1177
5. D.M. Fleischer, T.T. Perry, D. Atkins, R.A. Wood, A.W. Burks, S.M. Jones, and et al. Allergic reactions to foods in preschool-aged children in a prospective observational food allergy study Pediatrics 130 2012 e25 32
6. T. Boyano-Martinez, C. Garcia-Ara, M. Pedrosa, J.M. Diaz-Pena, and S. Quirce Accidental allergic reactions in children allergic to cow's milk proteins J Allergy Clin Immunol 123 2009 883 888
7. J.M. Skripak, S.D. Nash, H. Rowley, N.H. Brereton, S. Oh, R.G. Hamilton, and et al. A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy J Allergy Clin Immunol 122 2008 1154 1160
8. G. Longo, E. Barbi, I. Berti, R. Meneghetti, A. Pittalis, L. Ronfani, and et al. Specific oral tolerance induction in children with very severe cow's milk-induced reactions J Allergy Clin Immunol 121 2008 343 347
9. P. Meglio, P.G. Giampietro, S. Gianni, and E. Galli Oral desensitization in children with immunoglobulin E-mediated cow's milk allergy - follow-up at 4 yr and 8 months Pediatr Allergy Immunol 19 2008 412 419
10. C.A. Keet, P.A. Frischmeyer-Guerrerio, A. Thyagarajan, J.T. Schroeder, R.G. Hamilton, S. Boden, and et al. The safety and efficacy of sublingual and oral immunotherapy for milk allergy J Allergy Clin Immunol 129 2012 448 455 e1-5
11. U. Staden, C. Rolinck-Werninghaus, F. Brewe, U. Wahn, B. Niggemann, and K. Beyer Specific oral tolerance induction in food allergy in children: efficacy and clinical patterns of reaction Allergy 62 2007 1261 1269
12. C.A. Keet, S. Seopaul, S. Knorr, S. Narisety, J. Skripak, and R.A. Wood Long-term follow-up of oral immunotherapy for cow's milk allergy J Allergy Clin Immunol 132 2013 737 739.e6
13. A.W. Burks, S.M. Jones, R.A. Wood, D.M. Fleischer, S.H. Sicherer, R.W. Lindblad, and et al. Oral immunotherapy for treatment of egg allergy in children N Engl J Med 367 2012 233 243
14. A. Syed, M.A. Garcia, S.C. Lyu, R. Bucayu, A. Kohli, S. Ishida, and et al. Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3) J Allergy Clin Immunol 133 2014 500 510
15. S.D. Narisety, P.A. Frischmeyer-Guerrerio, C.A. Keet, M. Gorelik, J. Schroeder, R.G. Hamilton, and et al. A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy J Allergy Clin Immunol 135 2015 1274 1282 e1-6
16. M. Gorelik, S.D. Narisety, A.L. Guerrerio, K.L. Chichester, C.A. Keet, A.P. Bieneman, and et al. Suppression of the immunologic response to peanut during immunotherapy is often transient J Allergy Clin Immunol 135 2015 1283 1292
17. T.B. Casale, W.W. Busse, J.N. Kline, Z.K. Ballas, M.H. Moss, R.G. Townley, and et al. Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis J Allergy Clin Immunol 117 2006 134 140
18. M. Massanari, H. Nelson, T. Casale, W. Busse, F. Kianifard, G.P. Geba, and et al. Effect of pretreatment with omalizumab on the tolerability of specific immunotherapy in allergic asthma J Allergy Clin Immunol 125 2010 383 389
19. K.C. Nadeau, L.C. Schneider, L. Hoyte, I. Borras, and D.T. Umetsu Rapid oral desensitization in combination with omalizumab therapy in patients with cow's milk allergy J Allergy Clin Immunol 127 2011 1622 1624
20. L.C. Schneider, R. Rachid, J. LeBovidge, E. Blood, M. Mittal, and D.T. Umetsu A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients J Allergy Clin Immunol 132 2013 1368 1374
21. F.L. van der Heijden, R.J. van Neerven, and M.L. Kapsenberg Relationship between facilitated allergen presentation and the presence of allergen-specific IgE in serum of atopic patients Clin Exp Immunol 99 1995 289 293
22. R.J. van Neerven, C.P. van Roomen, W.R. Thomas, M. de Boer, E.F. Knol, and F.M. Davis Humanized anti-IgE mAb Hu-901 prevents the activation of allergen-specific T cells Int Arch Allergy Immunol 124 2001 400 402
23. L.K. Wilcock, J.N. Francis, and S.R. Durham IgE-facilitated antigen presentation: role in allergy and the influence of allergen immunotherapy Immunol Allergy Clin North Am 26 2006 333 347 viii-ix
24. C. Prussin, D.T. Griffith, K.M. Boesel, H. Lin, B. Foster, and T.B. Casale Omalizumab treatment downregulates dendritic cell FcϵRI expression J Allergy Clin Immunol 112 2003 1147 1154
25. M.C. Berin Mucosal antibodies in the regulation of tolerance and allergy to foods Semin Immunopathol 34 2012 633 642
26. L.S. Ford, K.A. Bloom, A.H. Nowak-Wegrzyn, W.G. Shreffler, M. Masilamani, and H.A. Sampson Basophil reactivity, wheal size, and immunoglobulin levels distinguish degrees of cow's milk tolerance J Allergy Clin Immunol 131 2013 180 186 e1-3
27. R.G. Hamilton, G.V. Marcotte, and S.S. Saini Immunological methods for quantifying free and total serum IgE levels in allergy patients receiving omalizumab (Xolair) therapy J Immunol Methods 303 2005 81 91
28. D.Y. Leung, H.A. Sampson, J.W. Yunginger, A.W. Burks Jr., L.C. Schneider, C.H. Wortel, and et al. Effect of anti-IgE therapy in patients with peanut allergy N Engl J Med 348 2003 986 993
29. J.H. Savage, J.P. Courneya, P.M. Sterba, D.W. Macglashan, S.S. Saini, and R.A. Wood Kinetics of mast cell, basophil, and oral food challenge responses in omalizumab-treated adults with peanut allergy J Allergy Clin Immunol 130 2012 1123 1129.e2
30. H.A. Sampson, D.Y. Leung, A.W. Burks, G. Lack, S.L. Bahna, S.M. Jones, and et al. A phase II, randomized, doubleblind, parallelgroup, placebocontrolled oral food challenge trial of Xolair (omalizumab) in peanut allergy J Allergy Clin Immunol 127 2011 1309 1310.e1
31. N. Novak, S. Kraft, and T. Bieber Unraveling the mission of FcepsilonRI on antigen-presenting cells J Allergy Clin Immunol 111 2003 38 44
32. D. Maurer, C. Ebner, B. Reininger, E. Fiebiger, D. Kraft, J.P. Kinet, and et al. The high affinity IgE receptor (Fc epsilon RI) mediates IgE-dependent allergen presentation J Immunol 154 1995 6285 6290